alexa Why Molecular Biomarkers of Traumatic Brain Injury May Never Work: Effects of Glymphatic Pathway Dysfunction
ISSN: 2167-1222

Journal of Trauma & Treatment
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

Why Molecular Biomarkers of Traumatic Brain Injury May Never Work: Effects of Glymphatic Pathway Dysfunction

Sheng-He Huang1,2* and Yan-Hong Zhou1

1Hubei Bioinformatics and Molecular Imaging Key Laboratory, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, China

2Saban Research Institute of Childrens Hospital Los Angeles, Department of Pediatrics, University of Southern California, Los Angeles, California, USA

*Corresponding Author:
Sheng-He Huang
Saban Research Institute of Childrens Hospital Los Angeles
Department of Pediatrics
University of Southern California, Los Angeles
California, USA
Tel: +3233612322
E-mail: [email protected]

Received date: April 01, 2016; Accepted date: June 22, 2016; Published date: June 25, 2016

Citation: Huang HS, Zhou HY (2016) Why Molecular Biomarkers of Traumatic Brain Injury May Never Work: Effects of Glymphatic Pathway Dysfunction. J Trauma Treat 5: 309. doi:10.4172/2167-1222.1000309

Copyright: © 2016 Huang S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



Traumatic brain injury (TBI) is the leading cause of death and disability in children and young adults around the world because it has been the most misunderstood and misdiagnosed problem among the central nervous system (CNS) disorders. Around 90% of TBIs are classified as mild (mTBI). The current detection of mTBI relies heavily on an assessment of behavioral symptoms, often with delay and subject to motivation. Despite notable advances in diagnostic magnetic resonance imaging (MRI), it remains a challenging issue to precisely make early evaluation of the severity of TBI and to predict the long-term outcomes. Currently there are no molecular biomarker-based blood tests that can accurately determine the presence and the severity of TBI because at present no clinical tools are available for measuring glymphatic-derived convective bulk flow in humans. There is an urgent need to call for a concerted effort to search for sensitive and reliable biomarkers of TBI, especially mTBI. There is a growing consensus that TBI, no matter what the cause, leads to dysfunction of the blood-brain barrier (BBB), which is mainly constituted by brain microvascular endothelial cells (BMEC). Our recent preclinical studies have shown that circulating BMEC in the peripheral blood, which are independent of the glymphatic system, could be used as cellbased biomarkers for quantitative assessment of BBB injury caused by various pathogenic insults, including trauma. The vimentin-α7 nAChR pathway significantly contributes to cBMEC shedding during the pathogenesis of BBB/CNS disorders. The cell-based biomarkers cBMEC along with the single cell technology will overcome the limitations of molecular biomarkers mentioned above and make the early diagnosis of TBI.


Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version